Literature DB >> 29688263

Further evidence to support judicious use of antibiotics in patients with cancer.

J J Luke1, S K Pal2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29688263      PMCID: PMC6005023          DOI: 10.1093/annonc/mdy153

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  17 in total

1.  Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Authors:  Leore T Geller; Michal Barzily-Rokni; Tal Danino; Oliver H Jonas; Noam Shental; Deborah Nejman; Nancy Gavert; Yaara Zwang; Zachary A Cooper; Kevin Shee; Christoph A Thaiss; Alexandre Reuben; Jonathan Livny; Roi Avraham; Dennie T Frederick; Matteo Ligorio; Kelly Chatman; Stephen E Johnston; Carrie M Mosher; Alexander Brandis; Garold Fuks; Candice Gurbatri; Vancheswaran Gopalakrishnan; Michael Kim; Mark W Hurd; Matthew Katz; Jason Fleming; Anirban Maitra; David A Smith; Matt Skalak; Jeffrey Bu; Monia Michaud; Sunia A Trauger; Iris Barshack; Talia Golan; Judith Sandbank; Keith T Flaherty; Anna Mandinova; Wendy S Garrett; Sarah P Thayer; Cristina R Ferrone; Curtis Huttenhower; Sangeeta N Bhatia; Dirk Gevers; Jennifer A Wargo; Todd R Golub; Ravid Straussman
Journal:  Science       Date:  2017-09-15       Impact factor: 47.728

2.  Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.

Authors:  Jonathan U Peled; Sean M Devlin; Anna Staffas; Melissa Lumish; Raya Khanin; Eric R Littmann; Lilan Ling; Satyajit Kosuri; Molly Maloy; John B Slingerland; Katya F Ahr; Kori A Porosnicu Rodriguez; Yusuke Shono; Ann E Slingerland; Melissa D Docampo; Anthony D Sung; Daniela Weber; Amin M Alousi; Boglarka Gyurkocza; Doris M Ponce; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Ying Taur; Eric G Pamer; Robert R Jenq; Marcel R M van den Brink
Journal:  J Clin Oncol       Date:  2017-03-15       Impact factor: 44.544

Review 3.  Cancer immunotherapy using checkpoint blockade.

Authors:  Antoni Ribas; Jedd D Wolchok
Journal:  Science       Date:  2018-03-22       Impact factor: 47.728

4.  The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.

Authors:  Smruti Pushalkar; Mautin Hundeyin; Donnele Daley; Constantinos P Zambirinis; Emma Kurz; Ankita Mishra; Navyatha Mohan; Berk Aykut; Mykhaylo Usyk; Luisana E Torres; Gregor Werba; Kevin Zhang; Yuqi Guo; Qianhao Li; Neha Akkad; Sarah Lall; Benjamin Wadowski; Johana Gutierrez; Juan Andres Kochen Rossi; Jeremy W Herzog; Brian Diskin; Alejandro Torres-Hernandez; Josh Leinwand; Wei Wang; Pardeep S Taunk; Shivraj Savadkar; Malvin Janal; Anjana Saxena; Xin Li; Deirdre Cohen; R Balfour Sartor; Deepak Saxena; George Miller
Journal:  Cancer Discov       Date:  2018-03-22       Impact factor: 39.397

5.  Bacterial Metabolism Affects the C. elegans Response to Cancer Chemotherapeutics.

Authors:  Aurian P García-González; Ashlyn D Ritter; Shaleen Shrestha; Erik C Andersen; L Safak Yilmaz; Albertha J M Walhout
Journal:  Cell       Date:  2017-04-20       Impact factor: 41.582

6.  Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

Authors:  Noriho Iida; Amiran Dzutsev; C Andrew Stewart; Loretta Smith; Nicolas Bouladoux; Rebecca A Weingarten; Daniel A Molina; Rosalba Salcedo; Timothy Back; Sarah Cramer; Ren-Ming Dai; Hiu Kiu; Marco Cardone; Shruti Naik; Anil K Patri; Ena Wang; Francesco M Marincola; Karen M Frank; Yasmine Belkaid; Giorgio Trinchieri; Romina S Goldszmid
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

7.  Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.

Authors:  L Derosa; M D Hellmann; M Spaziano; D Halpenny; M Fidelle; H Rizvi; N Long; A J Plodkowski; K C Arbour; J E Chaft; J A Rouche; L Zitvogel; G Zalcman; L Albiges; B Escudier; B Routy
Journal:  Ann Oncol       Date:  2018-06-01       Impact factor: 32.976

8.  Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.

Authors:  Krista Dubin; Margaret K Callahan; Boyu Ren; Raya Khanin; Agnes Viale; Lilan Ling; Daniel No; Asia Gobourne; Eric Littmann; Curtis Huttenhower; Eric G Pamer; Jedd D Wolchok
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

9.  Human microbiome signatures of differential colorectal cancer drug metabolism.

Authors:  Leah Guthrie; Sanchit Gupta; Johanna Daily; Libusha Kelly
Journal:  NPJ Biofilms Microbiomes       Date:  2017-11-01       Impact factor: 7.290

10.  Extensive impact of non-antibiotic drugs on human gut bacteria.

Authors:  Lisa Maier; Mihaela Pruteanu; Michael Kuhn; Georg Zeller; Anja Telzerow; Exene Erin Anderson; Ana Rita Brochado; Keith Conrad Fernandez; Hitomi Dose; Hirotada Mori; Kiran Raosaheb Patil; Peer Bork; Athanasios Typas
Journal:  Nature       Date:  2018-03-19       Impact factor: 49.962

View more
  2 in total

Review 1.  Gut microbiota influence tumor development and Alter interactions with the human immune system.

Authors:  Yanshan Ge; Xinhui Wang; Yali Guo; Junting Yan; Aliya Abuduwaili; Kasimujiang Aximujiang; Jie Yan; Minghua Wu
Journal:  J Exp Clin Cancer Res       Date:  2021-01-25

2.  Antibiotic tigecycline inhibits cell proliferation, migration and invasion via down-regulating CCNE2 in pancreatic ductal adenocarcinoma.

Authors:  Jie Yang; Zhen Dong; Aishu Ren; Gang Fu; Kui Zhang; Changhong Li; Xiangwei Wang; Hongjuan Cui
Journal:  J Cell Mol Med       Date:  2020-03-06       Impact factor: 5.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.